Connect with us

Hi, what are you looking for?

Medicine

Can Moderna Deliver a Highly Effective Flu Vaccine?

Moderna, Inc.’s (NASDAQ: MRNA) vaccine franchise has further legs to play out, according to an analyst at Morgan Stanley.

The Moderna Analyst: Matthew Harrison has an Equal-weight rating and a $313 price target for Moderna shares.

The Moderna Thesis: The success of COVID-19 mRNA vaccines has led to the development of additional respiratory vaccines using the technology, Harrison said in a note.

Related Link: Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates

The next key vaccine readout, the analyst …

Full story available on Benzinga.com

Original Source: benzinga.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Medicine

Arbutus’ Lead Compound AB-729 Continues to be Safe and Effective at Reducing HBsAg in Patients with Chronic Hepatitis B HBsAg remains suppressed up to...

Medicine

PHILADELPHIA, Nov. 09, 2021 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC, the “Company”)), a biotechnology company with operations in China and the...

Medicine

COVID passes and vaccine passports may promise the ideal solution to avoiding further lockdowns in the UK or pose a threat to people’s freedoms...

Arts

The Fourth Single ‘Eyy Bidda Idhi Naa Adda’ From Allu Arjun’s Pushpa Is Out… The Fourth Single ‘Eyy Bidda Idhi Naa Adda’ From Allu...

ONBP.com